Respiratory
News on diagnostics for respiratory pathogens, including influenza, coronavirus, and more.
Domus Diagnostics Wins $2.4M NIH RADx Tech Contract
The firm will use the funding to validate a rapid, low-cost, zero-power multiplex assay for COVID-19, flu A and B, and respiratory syncytial virus.
FDA Grants Marketing Rights for InBios Point-of-Care Anthrax Test
The test, which diagnoses inhalation anthrax, provides results in about 20 minutes and is intended for use by military personnel and medical or healthcare professionals.
The new SpotFire system is significantly faster than other CLIA-waived syndromic tests, and a new test menu could provide even more advantages, the firm said.
Almac, AstraZeneca Strike CDx Development Pact
Almac will develop companion diagnostic for use with AstraZeneca pharmaceuticals in a range of therapeutic areas.
As the firm continues to develop assays to run on a current batch-based MDx system, it seeks to develop a more flexible, random-access testing platform.